Embolization of renal carcinoma

Area of Science:

• Urology
• Oncology
• Interventional Radiology

Background:

• Preoperative transcatheter embolization is a valuable tool for managing renal neoplasms.
• It is particularly beneficial for large, hypervascular tumors.
• Combining embolization with nephrectomy and hormonal therapy shows promise for renal carcinoma treatment.

Purpose of the Study:

• To evaluate the efficacy of preoperative transcatheter embolization combined with nephrectomy and hormonal therapy in managing renal carcinoma.
• To investigate the impact of the delay between embolization and nephrectomy on therapeutic response.

Main Methods:

• The study included 49 patients with known metastases.
• Transcatheter embolization of the renal artery was performed.
• Nephrectomy and hormonal therapy were administered 4 to 7 days after embolization.

Main Results:

• The combined treatment approach demonstrated a 36% response rate in patients with known metastases.
• The delay between embolization and nephrectomy appears to be a significant factor, though the optimal timing requires further establishment.

Conclusions:

• Preoperative transcatheter embolization, followed by nephrectomy and hormonal therapy within 4-7 days, can alter the disease course in patients with renal carcinoma and known metastases.
• This multimodal approach offers a promising strategy for managing advanced renal cancer.